CD70 is a member of the tumor necrosis factor (TNF) superfamily and has recently been considered as a potential target for AML; the normal expression of CD70 is restricted to activated immune cells, but its expression is increased in many cancer types. This evidence concerns the gene TNF and acute myeloid leukemia.